News

News

Roivios Receives FDA Breakthrough Device Designation for JuxtaFlow RAD

Roivios Wins FDA Breakthrough Nod for Renal Assist Device

Roivios® announces final patient enrollment in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

RoiviosTM announces first patient enrolled in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Check back here for the latest news and updates on our BIPASS-AKI clinical study and the JuxtaFlow® Renal Assist Device System.

Abstract global map representing data

Learn about our research

Find info about our clinical studies

See studies

Meet our Team

See what makes us different

Find company info

Contact Us

Connect with our team

Click here
Roivios Logo

Roivios, Ltd.
Albany Financial Center 
Suite 708 
South Ocean Boulevard 
New Providence
The Bahamas

Linkedin
3ivelabslogo

3ive Labs, LLC

1230 Upper Hembree Rd.

Suite 102

Roswell, GA 30076

USA

Linkedin

Contact Us

© 2023 All rights reserved​. Roivios, Ltd.